Everything below concerns pentadecapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-09-08. Numbers and descriptions here follow the published literature rather than marketing material.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Approximate, for sequence GEPPPGKPADDAGLV |
| Molecular mass | ~1419 Da | Neutral form |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Typical storage | -20 C | Dry powder, protected from moisture |
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
The College of Allied Health Sciences (CAHS) provides education for allied health and health science professionals. CAHS became a college at the University of Cincinnati in March 1998. Its programs originated from various colleges at the University of Cincinnati.
In 2016, a set of 355 genes likely present in the LUCA was identified. A total of 6.1 million prokaryotic genes from Bacteria and Archaea were sequenced, identifying 355 protein clusters from among 286,514 protein clusters that were probably common to the LUCA. The results suggest that the LUCA was anaerobic with a Wood–Ljungdahl (reductive Acetyl-CoA) pathway, nitrogen- and carbon-fixing, thermophilic. Its cofactors suggest dependence upon an environment rich in hydrogen, carbon dioxide, iron, and transition metals. Its genetic material was probably DNA, requiring the 4-nucleotide genetic code, messenger RNA, transfer RNA, and ribosomes to translate the code into proteins such as enzymes. LUCA likely inhabited an anaerobic hydrothermal vent setting in a geochemically active environment. It was evidently already a complex organism, and must have had precursors; it was not the first living thing. The physiology of LUCA has been in dispute. Previous research identified 60 proteins common to all life. Metabolic reactions inferred in LUCA are the incomplete reverse Krebs cycle, gluconeogenesis, the pentose phosphate pathway, glycolysis, reductive amination, and transamination.
== Function == The ELN gene encodes a protein that is one of the two components of elastic fibers. The encoded protein is rich in hydrophobic amino acids such as glycine and proline, which form mobile hydrophobic regions bounded by crosslinks between lysine residues. Multiple transcript variants encoding different isoforms have been found for this gene. Elastin's soluble precursor is tropoelastin.
Natural fibers are also used in composite materials, much like synthetic or glass fibers. These composites, called biocomposites, are a natural fiber in a matrix of synthetic polymers. One of the first biofiber-reinforced plastics in use was a cellulose fiber in phenolics in 1908. Usage includes applications where energy absorption is important, such as insulation, noise absorbing panels, or collapsable areas in automobiles. Natural fibers can have different advantages over synthetic reinforcing fibers. Most notably they are biodegradable and renewable. Additionally, they often have low densities and lower processing costs than synthetic materials. Design issues with natural fiber-reinforced composites include poor strength (natural fibers are not as strong as glass fibers) and difficulty with actually bonding the fibers and the matrix. Hydrophobic polymer matrices offer insufficient adhesion for hydrophilic fibers.
Sources: en.wikipedia.org
=== Osteocyte === Osteocytes are cells of mesenchymal origin and originate from osteoblasts that have migrated into and become trapped and surrounded by a bone matrix that they themselves produced. The spaces the cell body of osteocytes occupy within the mineralized collagen type I matrix are known as lacunae, while the osteocyte cell processes occupy channels called canaliculi. The many processes of osteocytes reach out to meet osteoblasts, osteoclasts, bone lining cells, and other osteocytes probably for the purposes of communication. Osteocytes remain in contact with other osteocytes in the bone through gap junctions—coupled cell processes which pass through the canalicular channels.
=== Promethium === In the second half of the 20th century, radium was progressively replaced with paint containing promethium-147. Promethium is a low-energy beta-emitter, which, unlike alpha emitters like radium, does not degrade the phosphor lattice, so the luminosity of the material will not degrade so quickly. It also does not emit the penetrating gamma rays which radium does. The half-life of 147Pm is only 2.62 years, so in a decade the radioactivity of a promethium dial will decline to only 1/16 of its original value, making it safer to dispose of, compared to radium with its half-life of 1600 years. This short half-life meant that the luminosity of promethium dials also dropped by half every 2.62 years, giving them a short useful life, which led to promethium's replacement by tritium. Promethium-based paint was used to illuminate Apollo Lunar Module electrical switch tips and painted on control panels of the Lunar Roving Vehicle.
On 29 March, Trump stated that he would prefer to "take the oil in Iran". He proposed taking Iran's oil export center, Kharg Island, claiming that the United States could capture the territory "very easily", and implying that the US could occupy it for some time. On 30 March, Trump said that if a deal were not reached soon and the Strait of Hormuz reopened, the US would strike all of Iran's power plants, oil wells, Kharg Island, and possibly all its desalinization plants, although the feasibility and strategic value of some of Trump's threats were contested. On the same day Turkey and NATO intercepted the fourth missile directed towards Turkish territory. Iran denied firing a missile at Turkey, claiming that it was a false flag attack. The US began flying B-52 bombers over Iranian territory for the first time, indicating its confidence of air supremacy over Iran. The US used bombers to target an ammunition depot and air base in Isfahan, causing large explosions. U.S-allied Gulf states such as Saudi Arabia, the UAE, Kuwait, and Bahrain reportedly pushed Trump to continue the war until there are significant changes in Iran's leadership. American journalist Shelly Kittleson was kidnapped in Baghdad by Kata'ib Hezbollah—the strongest faction within the PMF—who demanded that the Iraqi government release several detained members of the group. On 1 April, Mehr News Agency, a semi-official Iranian government news outlet, reported that policy expert and former foreign minister Kamal Kharazi was seriously injured and his wife was killed in an airstrike which hit his home.
Sources: en.wikipedia.org
Also that year, Schumer wrote a memoir, entitled The Girl with the Lower Back Tattoo. It held the top position on The New York Times Non-Fiction Best Seller list for two weeks in September 2016 and garnered her a nomination for the Grammy Award for Best Spoken Word Album. Schumer made her Broadway debut in 2017 acting in Steve Martin's comedy play Meteor Shower alongside Keegan-Michael Key, Laura Benanti and Jeremy Shamos. The play revolves around two couples in 1993 who spend an evening with each other. David Rooney of The Hollywood Reporter wrote "Schumer is one of four terrific performers who juice the entertainment of this high-sheen production...which would never have made it this far without Martin's name behind it, or more crucially, without the marquee draw of Schumer making her Broadway debut." Schumer was nominated for the Tony Award for Best Actress in a Play losing to Glenda Jackson for the revival of Edward Albee's Three Tall Women. In 2018, she starred in the comedy film I Feel Pretty which received negative reviews from critics. Spotify released the original podcast Amy Schumer Presents: 3 Girls, 1 Keith on June 21, 2018, starring Schumer and her best comedy friends Rachel Feinstein, Bridget Everett and Keith Robinson as they talk about comedy, pop culture, politics and their personal lives. She released her standup special Amy Schumer: Growing (2019) on Netflix to positive reviews. Schumer received a Primetime Emmy Award for Outstanding Writing for a Variety Special nomination.
=== Notable product use === Bruker products are used globally in a variety of situations. The National High Magnetic Field Laboratory at Florida State University selected Bruker to build the world's first 21.0 tesla FT-ICR MS. The Total Carbon Column Observing Network uses high resolution FT-IR spectrometers made by Bruker to measure various greenhouse gases across the globe.
=== Recombinant preparations === Follitropin alfa Generic Follitropin alfa injection Brands Gonal-f Cinnal-f Fertilex Ovaleap Bemfola Generic Follitropin alfa / lutropin alfa combination Brands Pergoveris Follitropin beta Generic follitropin beta injection Brands Follistim AQ Puregon Follitropin delta Generic follitropin delta injection Brands Rekovelle The package insert for Gonal-f states that based on physio-chemical tests and bioassays that follitropin beta and follitropin alfa are indistinguishable. Two studies showed no difference. However, a more recent study showed there may be a slight clinical difference, with the alfa form tending towards a higher pregnancy rate and the beta form tending towards a lower pregnancy rate, but with significantly higher estradiol (E2) levels. The package insert for Puregon states that structural analysis shows that the amino acid sequence of follitropin beta is identical to that of natural human follicle stimulating hormone (hFSH). Further, the ogliosaccharide side chains are very similar, but not completely identical to that of natural hFSH. However, these small differences do not affect the bioactivity compared to natural hFSH. Gonal-f was approved for medical use in the European Union in October 1995. Puregon was approved for medical use in the European Union in February 1996. Rekovelle was approved for medical use in the European Union in December 2016.
The next incarnation of King Crimson was radically different from the previous configurations. Fripp's four new recruits were free-improvising percussionist Jamie Muir; drummer Bill Bruford, who had left Yes at a critical and commercial peak in their career in favour of the "darker" Crimson; bassist and vocalist John Wetton, who left Family; and violinist, keyboardist and flautist David Cross, whom Fripp had met when he was invited to a rehearsal of Waves, a band Cross was working in. Fripp and Wetton were this incarnation's primary composers, each writing segments independently and fitting together those which they found compatible. With Sinfield gone, the band asked Wetton's friend Richard Palmer-James, formerly of Supertramp, to be their new lyricist. Unlike Sinfield, Palmer-James was not an official member of King Crimson, having no involvement with the band other than writing lyrics, which he would mail to them from his home in Germany. Following a period of rehearsals, King Crimson resumed touring on 13 October 1972 at the Zoom Club in Frankfurt, with the band's penchant for improvisation and Muir's startling stage presence gaining them renewed press attention.
Sources: en.wikipedia.org
The letters BPC stand for body protection compound. The number 157 refers to a specific fragment designation from early work on gastric proteins. The full name is a label for a synthetic fifteen-amino-acid peptide rather than a naturally isolated drug.
No. The gastric protein is larger, while BPC-157 is a short fragment sequence. The peptide is produced synthetically for research use. The relationship is one of sequence origin, not chemical identity.
It is most often supplied as a lyophilized powder, frequently as the acetate salt. The powder is reconstituted with water or a buffer before use. Free-base and other salt forms also exist but are less common in catalogs.
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.